Azilsartan medoxomil

Details

Files

Generic Name:

Azilsartan medoxomil

Project Status:

Complete

Therapeutic Area:

Hypertension

Manufacturer:

Takeda Canada Inc.

Call for patient/clinician input open:

March 8, 2013

Brand Name:

Edarbi

Project Line:

Reimbursement Review

Project Number:

SR0317-000

Call for patient/clinician input closed:

March 29, 2013

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Hypertension, essential

Recommendation Type:

Do not list at the submitted price

Final Recommendation:

October 17, 2013

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : March 8, 2013